The HIV-1 Envelope Transmembrane Domain Binds TLR2 through a Distinct Dimerization Motif and Inhibits TLR2-Mediated Responses

English version České info

To understand viral pathology and the tools needed to eliminate infection, it is important to understand how viral immune evasion occurs. One such mode of inhibition is the decreased responsiveness of Toll-Like Receptors (TLRs). To date, the exact mechanism inducing this inhibition is not clear. In this study, we utilized a multidisciplinary approach and report on direct modulation of TLR2 activity by the envelope trans-membrane protein of HIV-1 through trans-membrane domain interactions. This interaction resulted in a decreased response in vitro of TLR2 to its natural ligand LTA. Through mutagenesis analysis we show that the GxxxG motif is the driving force of this interaction. Interestingly, the inhibitory effect was also highly effective in protecting mice from lethal effects in a sepsis-like model. Our findings implicate that ENV participates in innate immune impairment, which may occur during viral entry and at latent stages. Furthermore, due to the high functional homology between viral ENV proteins, this function may exhibit a general character of viral-induced immune modulation.

Vyšlo v časopise: The HIV-1 Envelope Transmembrane Domain Binds TLR2 through a Distinct Dimerization Motif and Inhibits TLR2-Mediated Responses. PLoS Pathog 10(8): e32767. doi:10.1371/journal.ppat.1004248
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004248

Souhrn

Zdroje

1. CassolE, AlfanoM, BiswasP, PoliG (2006) Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol 80: 1018–1030.

2. KirchhoffF (2010) Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8: 55–67.

3. ManelN, LittmanDR (2011) Hiding in plain sight: how HIV evades innate immune responses. Cell 147: 271–274.

4. AhmedZ, CzubalaM, BlanchetF, PiguetV (2012) HIV impairment of immune responses in dendritic cells. Adv Exp Med Biol 762: 201–238.

5. DoehleBP, HladikF, McNevinJP, McElrathMJ, GaleMJr (2009) Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol 83: 10395–10405.

6. SasaiM, YamamotoM (2013) Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors. Int Rev Immunol 32: 116–133.

7. SongDH, LeeJO (2012) Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev 250: 216–229.

8. KirschningCJ, SchumannRR (2002) TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 270: 121–144.

9. WerlingD, JungiTW (2003) TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 91: 1–12.

10. AkiraS, TakedaK (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499–511.

11. JinMS, KimSE, HeoJY, LeeME, KimHM, et al. (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130: 1071–1082.

12. MonieTP, BryantCE, GayNJ (2009) Activating immunity: lessons from the TLRs and NLRs. Trends Biochem Sci 34: 553–561.

13. FinkA, ReuvenEM, ArnuschCJ, Shmuel-GaliaL, AntonovskyN, et al. (2013) Assembly of the TLR2/6 Transmembrane Domains Is Essential for Activation and Is a Target for Prevention of Sepsis. J Immunol 190: 6410–6422.

14. VictoriaS, TemerozoJR, GobboL, Pimenta-InadaHK, Bou-HabibDC (2013) Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection. Immunobiology

15. MartinsonJA, Roman-GonzalezA, TenorioAR, MontoyaCJ, GichingaCN, et al. (2007) Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands. Cell Immunol 250: 75–84.

16. TriantafilouM, MiyakeK, GolenbockDT, TriantafilouK (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115: 2603–2611.

17. FesslerMB, ParksJS (2011) Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol 187: 1529–1535.

18. SunZY, OhKJ, KimM, YuJ, BrusicV, et al. (2008) HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28: 52–63.

19. BarbalatR, LauL, LocksleyRM, BartonGM (2009) Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 10: 1200–1207.

20. CohenT, CohenSJ, AntonovskyN, CohenIR, ShaiY (2011) HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation. PLoS Pathog 6: e1001085.

21. SchneiderD, EngelmanDM (2004) Motifs of two small residues can assist but are not sufficient to mediate transmembrane helix interactions. J Mol Biol 343: 799–804.

22. GhoshTK, MickelsonDJ, FinkJ, SolbergJC, InglefieldJR, et al. (2006) Toll-like receptor (TLR) 2–9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Cell Immunol 243: 48–57.

23. FinkA, Sal-ManN, GerberD, ShaiY (2012) Transmembrane domains interactions within the membrane milieu: principles, advances and challenges. Biochim Biophys Acta 1818: 974–983.

24. CymerF, SandersCR, SchneiderD (2013) Analyzing oligomerization of individual transmembrane helices and of entire membrane proteins in E. coli: A hitchhiker's guide to GALLEX. Methods Mol Biol 932: 259–276.

25. ZhanJ, DengR, TangJ, ZhangB, TangY, et al. (2006) The spleen as a target in severe acute respiratory syndrome. Faseb J 20: 2321–2328.

26. Farfel-BeckerT, VitnerEB, KellySL, BameJR, DuanJ, et al. (2013) Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Hum Mol Genet 23: 843–854.

27. HeL, ShobnamN, HristovaK (2011) Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain. Biochim Biophys Acta 1808: 253–259.

28. YinH, SluskyJS, BergerBW, WaltersRS, VilaireG, et al. (2007) Computational design of peptides that target transmembrane helices. Science 315: 1817–1822.

29. FragosoR, RenD, ZhangX, SuMW, BurakoffSJ, et al. (2003) Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol 170: 913–921.

30. TriantafilouM, LepperPM, OldenR, DiasIS, TriantafilouK (2011) Location, location, location: is membrane partitioning everything when it comes to innate immune activation? Mediators Inflamm 2011: 186093.

31. OgawaY, KawamuraT, KimuraT, ItoM, BlauveltA, et al. (2009) Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113: 5157–5166.

32. WilleyRL, BonifacinoJS, PottsBJ, MartinMA, KlausnerRD (1988) Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci U S A 85: 9580–9584.

33. OkoyeAA, PickerLJ (2013) CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev 254: 54–64.

34. SundstromJB, LittleDM, VillingerF, EllisJE, AnsariAA (2004) Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J Immunol 172: 4391–4401.

35. SchwarzerR, LeventalI, GramaticaA, ScolariS, BuschmannV, et al. (2014) The cholesterol-binding motif of the HIV-1 glycoprotein gp41 regulates lateral sorting and oligomerization. Cell Microbiol in press.

36. CohenT, Pevsner-FischerM, CohenN, CohenIR, ShaiY (2008) Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor. Biochemistry 47: 4826–4833.

37. SchneiderD, EngelmanDM (2003) GALLEX, a measurement of heterologous association of transmembrane helices in a biological membrane. J Biol Chem 278: 3105–3111.